oral semaglutide provider FDA Approves as the First Oral GLP-1 Pill FDA Approves Oral Semaglutide as

FDA for a new drug license (NDA) to use the oral "semaglutide 25 mg" as an indication for obesity and weight management

Does semaglutide damage the gut microbiome

Reuben A, Zhang J, Gittelman R, Chiou SH, Li J, Fujimoto J, Behrens C, Kheradmand F, Chow CW, Bernatchez C, Eterovic AK, Benzeno S, Vignali M, Wu X, Ye Y, Cascone T, Rerbst R, Swisher SG , Kadara H, Moran C, Zhang J, Scheet P, Vaporciyan A, Sepesi B, Gibbons D, Robins H, Hwu P, Heymach J, Sharma P, Allison J, Lee J, Davis M, Wistuba I, Futreal A, Zhang J

Of those patients, 710 had type 2 diabetes, 194 of whom had been prescribed semaglutide, and 975 were overweight, 361 of whom had been prescribed semaglutide